Coronavirus Disease 2019 (COVID-19) has become a pandemic since March 2020. We describe here 2 cases of COVID-19 infection in a posttransplant setting. First one is a 59-year-old renal transplant recipient; the second is a 51-year-old allogeneic bone marrow transplant recipient. Both patients were on immunosuppressant therapy and had stable graft function before COVID-19 infection. After the diagnosis of COVID-19, immunosuppressive agents were discontinued and methylprednisolone with prophylactic antibiotics were initiated, however, the lung injury progressed. The T cells were extremely low in both patients after infection. Both patients died despite the maximal mechanical ventilatory support. Therefore, the prognosis of COVID-19 pneumonia following transplantation is not optimistic and remains guarded. Lower T cell count may be a surrogate for poor outcome.
CITATION STYLE
Huang, J., Lin, H., Wu, Y., Fang, Y., Kumar, R., Chen, G., & Lin, S. (2020). COVID-19 in posttransplant patients—report of 2 cases. American Journal of Transplantation, 20(7), 1879–1881. https://doi.org/10.1111/ajt.15896
Mendeley helps you to discover research relevant for your work.